XURIDEN (Wellstat Therapeutics Corporation)
Welcome to the PulseAid listing for the XURIDEN drug offered from Wellstat Therapeutics Corporation. This Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Wellstat Therapeutics Corporation |
| NON-PROPRIETARY NAME: | uridine triacetate |
| SUBSTANCE NAME: | URIDINE TRIACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Pyrimidine Analog [EPC],Pyrimidines [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | GRANULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-09-08 |
| END MARKETING DATE: | 0000-00-00 |
XURIDEN HUMAN PRESCRIPTION DRUG Details:
| Item Description | XURIDEN from Wellstat Therapeutics Corporation |
| LABELER NAME: | Wellstat Therapeutics Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 951(mg/g) |
| START MARKETING DATE: | 2015-09-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69468-152_29cafd5d-9280-4b9b-9e8a-39cceb68461c |
| PRODUCT NDC: | 69468-152 |
| APPLICATION NUMBER: | NDA208169 |
Other URIDINE TRIACETATE Pharmaceutical Manufacturers / Labelers:
